Minnesota HF4852 allows Formulary Committee members with potential conflicts of interest to participate in communications and discussions, mandates a.

Minnesota HF4852 amends the state's health statutes to permit Formulary Committee members with potential conflicts of interest to participate in committee communications and discussions. The bill requires the commissioner of human services to develop a public comment process for recommendations made by the Formulary Committee. Additionally, the committee is mandated to seek expertise from the Minnesota Rare Disease Advisory Council. The bill outlines procedures for disclosing conflicts of interest and ensures public participation in the decision-making process.

Minnesota HF4852 allows Formulary Committee members with potential conflicts of interest to participate in communications and discussions, mandates a.

Minnesota HF4852 amends the state's health statutes to permit Formulary Committee members with potential conflicts of interest to participate in committee communications and discussions. The bill requires the commissioner of human services to develop a public comment process for recommendations made by the Formulary Committee. Additionally, the committee is mandated to seek expertise from the Minnesota Rare Disease Advisory Council. The bill outlines procedures for disclosing conflicts of interest and ensures public participation in the decision-making process.